Of 20 blood specimens testing positive for cytomegalovirus antigen after immediate processing, 19 (95%) remained positive when kept at room temperature for 24 h before processing. Quantitative antigenemia decreased by an average of 44% after storage. Compared with acetone fixation, formaldehyde fixation showed improved readability, fewer artifacts, and a higher degree of sensitivity.
Several modifications of the cytomegalovirus (CMV) antigenemia assay have been proposed in recent publications, and some of these modifications are reported to increase the sensitivity of the assay, thereby potentially also altering predictive values and quantitative levels for the correlation with CMV disease (2, 3, 7) . While the infectivities of blood specimens for culture inoculation appear to be preserved reasonably well for 48 h at 4°C (5) , it is still controversial whether blood specimens can be stored for antigenemia testing (3, (8) (9) (10) 15) . The purpose of the present study was to determine factors such as storage and the fixation method (i.e., acetone versus formaldehyde fixation) that may influence assay sensitivity.
Twenty milliliters of heparinized blood obtained from CMVseropositive patients who underwent marrow transplantation was divided in two 10-ml tubes. The patients selected for these studies either were known to be antigenemia positive or were at high risk of being antigenemia positive. The contents of one tube were processed immediately (less than 2 h after the blood was drawn), while the contents of the other tube were divided into two portions, and 5 ml was held at room temperature (range, 20 to 22°C; all specimens) and 5 ml was placed on ice for 24 h (n = 11). In addition, in a subset of specimens, the leukocyte pellet was held in 0.2 ml of phosphate-buffered saline (PBS) at 4°C for 24 h. Processing of heparinized blood and preparation of cytospin slides were performed as described earlier (2, 14) . Slides were fixed either in cold water-free acetone for 10 min (2) or by a formaldehyde-based staining method as described by Gerna et al. (3) . Briefly, slides were placed in formaldehyde-sucrose solution (5% of F-1635 and 2% of S-9378 in PBS; both from Sigma Chemical Co., St. Louis, Mo.) for 10 min at room temperature, washed four times in PBS-1% fetal calf serum (FCS), and subsequently immersed in PBS-0.5% Nonidet P-40 (N-6507; Sigma)-10% sucrose-I% FCS for 5 min at room temperature for permeabilization. After washing the slides four times in PBS-1% FCS as described above and placing the slides in distilled water for 15 s, the slides were air dried and were either stained or stored at -20°C.
Immunofluorescence staining was performed as described earlier (2 The results of the storage experiments are given in Table 2 and detail only slides fixed with formaldehyde. Of the specimens for which additional slides were fixed with acetone, all remained positive, with a mean decrease of antigen-positive cells per slide of 42% (range, 0 to 75%) and 56% (range, 21 to 87%) when the slides were held at room temperature (n = 10) and on ice (n = 6), respectively. Three cell pellet specimens were stored at 4°C for 24 h. Although the specimens remained positive, the experiment was discontinued because of poor cell morphology.
A comparison of a 45-min incubation time at room temperature (2) versus incubation for 30 min at 37°C for both the monoclonal antibody and the fluorescein isothiocyanate conjugates (3) for 15 specimens from known antigenemia-positive patients showed that there was not a significant quantitative difference in quantitative antigenemia (P = 0.44).
Our results are in agreement with those of two studies comparing formaldehyde fixation, acetone-methanol fixation (3), and acetone fixation (7). We also found a bright nuclear staining pattern with formaldehyde fixation, whereas we found perinuclear staining when we used acetone fixation, and the number of fluorescing nuclei per positive specimen was slightly improved (Table 1) results (8) . In contrast, results of our study suggest that overnight storage only rarely results in the reaction of a positive specimen as negative, although the quantity of antigenemia may decrease by as much as 44% (Table 2) . Nevertheless, every attempt should be undertaken to process the specimens without delay or at least to prepare the cytocentrifuge preparations on the same day. These slides can be stored at room temperature or at 4°C overnight, and staining can then be performed on the next day without a decrease in the level of quantitative antigenemia (data not shown). If overnight shipment cannot be avoided, this fact must be considered when interpreting the results. This may be particularly significant in low-positive specimens (i.e., fewer than five positive cells per slide), since it may result in false-negative results. Such a situation can occur early during CMV reactivation or during antiviral treatment. Specimens should be sent at room temperature for optimal preservation of the viral antigen (Table 2) . Numerous studies in transplant recipients and patients with AIDS have shown that the assay is a highly sensitive, specific, and predictive test for the rapid diagnosis of CMV in blood specimens (2, 4, 6, 7, (11) (12) (13) (14) . Additional advantages of the assay include the rapidity of processing and the lack of a requirement for cell culture, both of which result in lower costs and a low number of noninterpretable results. One of the most important features of the antigenemia assay is that it can be quantified and that high levels of antigenemia appear to correlate with CMV disease (2, 4, 6, (10) (11) (12) (13) (14) . An application that is particularly promising is the use of quantitative antigenemia to predict CMV disease, thereby allowing the clinician to stratify the patient's risk for disease (2, 10, 12) . Also, quantitative antigenemia may be useful for monitoring antiviral treatment and for predicting the recurrence of disease after an initial course of antiviral treatment (2, 3, 10, 13) . However, breakpoints of antigenemia may be different between patient populations (2, 10, 12) . For example, in renal transplant patients, an antigenemia level of more than 10 positive cells per slide is predictive of disease (10, 11) , while in bone marrow transplant patients, levels of more than 1 positive cell per slide are highly predictive of subsequent disease (2) . A concept that appears to be consistent in all patient populations is that rapidly rising levels of antigenemia are predictive of subsequent CMV disease (2, 4, 6, (10) (11) (12) (13) This study was supported by the American Cancer Society (RD-361) and the National Institutes of Health (CA 18029). Monoclonal antibodies and the fluorescein isothiocyanate conjugate were provided by Biotest Diagnostics Corp., Denville, N.J.
We are indebted to Ted Gooley for statistical calculations.
